Project Number 3R01AG040092-02S1 Agency/Funding Organization NIA Funding Year 2013 View Full Project Details for PYROGLUTAMATE AMYLOID-BETA AS AN IMMUNOTHERAPEUTIC TARGET FOR ALZHEIMER'S DISEASE Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category A. Molecular Pathogenesis and Physiology of Alzheimer's Disease and Alzheimer's Disease-related Dementias (AD/ADRDs) 9. Immunity and Inflammation d. Immunotherapy - Mechanisms of Action Researcher and Organization Principal Investigator LEMERE, CYNTHIA A Principal Investigator First Name CYNTHIA A Principal Investigator Last Name LEMERE Awardee Organization BRIGHAM AND WOMEN'S HOSPITAL Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA-11-260: RESEARCH PROJECT GRANT (PARENT R01) FY Overall Cost $155,800 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Related Resources Repository [AlzPED] An anti-pyroglutamate-3 Abeta vaccine reduces plaques and improves cognition in APPswe/PS1dE9 mice
